Literature DB >> 10678972

Colonic bacteria express an ulcerative colitis pANCA-related protein epitope.

O Cohavy1, D Bruckner, L K Gordon, R Misra, B Wei, M E Eggena, S R Targan, J Braun.   

Abstract

Bacteria are a suspected pathogenic factor in inflammatory bowel disease, but the identity of the relevant microbial species remains unresolved. The pANCA autoantibody is associated with most cases of ulcerative colitis (UC) and hence reflects an immune response associated with the disease process. This study addresses the hypothesis that pANCA identifies an antigen(s) expressed by bacteria resident in the human colonic mucosa. Libraries of colonic bacteria were generated using aerobic and anaerobic microbiologic culture conditions, and bacterial pools and clonal isolates were evaluated for cross-reactive antigens by immunoblot analysis using the pANCA monoclonal antibody Fab 5-3. Two major species of proteins immunoreactive to pANCA monoclonal antibodies were detected in bacteria from the anaerobic libraries. Colony isolates of the expressing bacteria were identified as Bacteroides caccae and Escherichia coli. Isolation and partial sequencing of the B. caccae antigen identified a 100-kDa protein without database homologous sequences. The E. coli protein was biochemically and genetically identified as the outer membrane porin OmpC. Enzyme-linked immunosorbent assay with human sera demonstrated elevated immunoglobulin G anti-OmpC in UC patients compared to healthy controls. These findings demonstrate that a pANCA monoclonal antibody detects a recurrent protein epitope expressed by colonic bacteria and implicates colonic bacterial proteins as a target of the disease-associated immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678972      PMCID: PMC97313          DOI: 10.1128/IAI.68.3.1542-1548.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

Review 1.  A new era for cancer immunotherapy based on the genes that encode cancer antigens.

Authors:  S A Rosenberg
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

Review 2.  Ultramicroanalysis of peptide profiles in biological samples using MALDI mass spectrometry.

Authors:  C R Jiménez; A L Burlingame
Journal:  Exp Nephrol       Date:  1998 Sep-Oct

Review 3.  The influence of normal microbial flora on the development of chronic mucosal inflammation.

Authors:  R B Sartor
Journal:  Res Immunol       Date:  1997 Oct-Dec

Review 4.  The role of the fecal stream in Crohn's disease: an historical and analytic review.

Authors:  H D Janowitz; E C Croen; D B Sachar
Journal:  Inflamm Bowel Dis       Date:  1998-02       Impact factor: 5.325

5.  High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis.

Authors:  J Sobajima; S Ozaki; H Uesugi; F Osakada; M Inoue; Y Fukuda; H Shirakawa; M Yoshida; A Rokuhara; H Imai; K Kiyosawa; K Nakao
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

6.  T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.

Authors:  R Duchmann; E May; M Heike; P Knolle; M Neurath; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

7.  pANCA represents a cross-reactivity to enteric bacterial antigens.

Authors:  F Seibold; S Brandwein; S Simpson; C Terhorst; C O Elson
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

8.  Biochemistry and regulation of a novel Escherichia coli K-12 porin protein, OmpG, which produces unusually large channels.

Authors:  D A Fajardo; J Cheung; C Ito; E Sugawara; H Nikaido; R Misra
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

9.  Amelioration of chronic ileitis by nitric oxide synthase inhibition.

Authors:  M J Miller; H Sadowska-Krowicka; S Chotinaruemol; J L Kakkis; D A Clark
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

10.  CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease.

Authors:  Y Cong; S L Brandwein; R P McCabe; A Lazenby; E H Birkenmeier; J P Sundberg; C O Elson
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

View more
  54 in total

Review 1.  Diagnostic methodologies: serology, endoscopy, and radiology.

Authors:  T Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2001-12

Review 2.  Recent advances in the diagnosis and classification of inflammatory bowel disease.

Authors:  Eric Vasiliauskas
Journal:  Curr Gastroenterol Rep       Date:  2003-12

Review 3.  Current concept of pathophysiological understanding and natural course of ulcerative colitis.

Authors:  Martin H Holtmann; Peter R Galle
Journal:  Langenbecks Arch Surg       Date:  2004-02-04       Impact factor: 3.445

4.  Current and future role of serogenomics in ulcerative colitis.

Authors:  Mark H Flasar; Raymond K Cross; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

5.  Review.

Authors:  Christopher B O'Brien
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

6.  Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.

Authors:  Marla Cindy Dubinsky
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

7.  Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.

Authors:  Hiromasa Takaishi; Takanori Kanai; Atsushi Nakazawa; Fumihiko Sugata; Akira Nikai; Shigeo Yoshizawa; Yasuo Hamamoto; Shinsuke Funakoshi; Tomoharu Yajima; Yasushi Iwao; Masao Takemura; Shoichi Ozaki; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-05-30       Impact factor: 7.527

Review 8.  The status of diagnostic markers for inflammatory bowel disease.

Authors:  Poonam Beniwal; Laura Harrell
Journal:  Curr Gastroenterol Rep       Date:  2010-12

9.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis.

Authors:  P R Fleshner; E A Vasiliauskas; L Y Kam; N E Fleshner; J Gaiennie; M T Abreu-Martin; S R Targan
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.